Trial · NCT06989697
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
NCT06989697, Phase 3, Recruiting, Seoul National University Bundang Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes. Trials, record NCT06989697. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06989697
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
- NCT number
- NCT06989697
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Seoul National University Bundang Hospital
- Conditions
- Type 2 Diabets Mellitus, Cognitive Ability, General
- Interventions
- Cilostazol / Ginko Leaf Dried Ext., Placebo
- First posted
- 2025-05-25
- Last updated
- 2025-05-25
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Mini-Mental State Examination (MMSE) Score From Baseline to 6 Months | 6 months | The MMSE is a widely used test of cognitive function among the elderly. It includes tests of orientation, attention, memory, language, and visual-spatial skills. Scores range from 0 to 30, with higher scores indicating better cognitive function. A change in total MMSE score from baseline to 6 months will be assessed. |
| Secondary | Change in Korean Dementia Screening Questionnaire (KDSQ) Score From Baseline to 6 Months | 6 months | The Korean Dementia Screening Questionnaire (KDSQ) is a caregiver- or self-administered tool used to screen for cognitive decline in older adults. It consists of 15 items, each scored from 0 to 2, for a total possible score of 0 to 30. Higher scores indicate greater cognitive impairment. A change in the total KDSQ score from baseline to 6 months will be assessed. |
| Secondary | Change in Korean Version of the Montreal Cognitive Assessment (K-MoCA) Score From Baseline to 6 Months | 6 months | The K-MoCA is a cognitive screening tool used to detect mild cognitive impairment and early dementia (https://mocacognition.com/paper/). It assesses multiple domains including attention, executive function, memory, language, visuospatial skills, abstraction, calculation, and orientation. Higher scores indicate better cognitive function (Score Range: 0 to 30). A change in the total K-MoCA score from baseline to 6 months will be assessed. |
| Secondary | Change in Global Deterioration Scale (GDS) Stage From Baseline to 6 Months | 6 months | The GDS is a clinical tool used to assess the severity of cognitive decline, particularly in Alzheimer's disease and other dementias. It includes 7 stages, ranging from: Stage 1: No cognitive decline \~ Stage 7: Very severe cognitive decline. Higher scores indicate more severe cognitive impairment. A change in the GDS stage from baseline to 6 months will be recorded based on clinical assessment. |
| Secondary | Change in Short Form-36 Health Survey (SF-36) Scores From Baseline to 6 Months | 3, 6 months | The SF-36 Health Survey is a 36-item, patient-reported questionnaire that assesses health-related quality of life across 8 domains: Physical Functioning, Role Limitations due to Physical Health, Role Limitations due to Emotional Problems, Energy/Fatigue (Vitality), Emotional Wellbeing (Mental Health), Social Functioning, Pain (Bodily Pain), General Health Perceptions. Each domain is scored separately on a scale from 0 to 100, with higher scores indicating better health status. Summary scores, such as the Physical Component Summary (PCS) and Mental Component Summary (MCS), may also be calculated. Changes in domain and/or summary scores from baseline to 6 months will be assessed. |
| Other | Glucose regulation | 3, 6 months | Change in HbA1c level From Baseline to 6 Months |
| Other | Lipid Panel | 3, 6 months | Change in Lipid Profile From Baseline to 6 Months |
| Other | Renal Function | 3, 6 months | Change in estimated glomerular filtration rate (eGFR, mL/min/1.73 m²) from baseline to 6 Months |
| Other | Liver Function | 3, 6 months | Change in Liver Function (AST, ALT) From Baseline to 6 Months |
| Other | C-Reactive Protein | 6 months | Change in hsCRP Levels From Baseline to 6 Months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06989697
GET https://conductscience.org/api/trials/v1/NCT06989697/registered